Please login to the form below

pricing model

This page shows the latest pricing model news and features for those working in and with pharma, biotech and healthcare.

based pricing model.

New trial results suggest CAR-T effects are durable in lymphoma

Ultimately, the winning player could be the company that gets the pricing and access model just right and keeps the cost not insignificant production costs of CAR-T under close control.
Daily Brief

A major new study published in Nature Reviews calls for a ‘global revolution’in the pricing of new cancer drugs – and claims an algorithm could turn what some see as the ... The paper, titled Sustainability and affordability of cancer drugs: a
Duchenne UK and pharma partner pilot data-sharing HTA approach

These delays are worsened for diseases as there is often limited evidence available to meet the requirements for access and pricing decisions.”. ... The hope is that the model could also be used for other rare diseases and provide greater certainty
Post-Shkreli KaloBios pledges transparent pricing

The new pricing model "will guide the company's strategy and operations", according to new CEO Cameron Durrant, who has pledged to price its Chagas disease treatment benznidazole on the basis ... Our new pricing model is a commitment to define and
UK pharma's contribution to NHS hits £1bn mark

The AAR was announced by Minister for Life Sciences George Freeman in November 2014 after it became apparent that plans to replace the PPRS with a value-based pricing model - along

More from news
Approximately 0 fully matching, plus 18 partially matching documents found.

Brexit and Trump

that we need to return to servicing a high-volume, low-cost model in consumer healthcare, and a parity pricing model in Rx.
Pharma deals in September 2015

to pursue a “ robust” pricing model. ... Pharmaceuticals. He has also written a letter to employees to assuage their concerns over company's business model, potential exposure and the fall in the company's stock price (it fell
Interview: Richard Bergström, EFPIA

These are good examples of where legislation helps promote innovation, but unfortunately it's the access to markets, pricing and reimbursement that are deteriorating. ... I have worked very closely with the Swedish government to shape value-based-pricing.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

A roadmap to strategic drug pricing

A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... Pharma firms must identify products that will benefit from innovative pricing models, and then forge the types

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Add my company

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....